ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 2 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,388 | -64.3% | 10,386 | +45.4% | 0.00% | – |
| Q4 2022 | $323,620 | +7.2% | 7,144 | +24.4% | 0.00% | – |
| Q3 2022 | $302,000 | -68.2% | 5,742 | -71.2% | 0.00% | -100.0% |
| Q2 2022 | $950,000 | -35.4% | 19,972 | -1.7% | 0.00% | -50.0% |
| Q1 2022 | $1,471,000 | +18.1% | 20,324 | +17.7% | 0.00% | +100.0% |
| Q4 2021 | $1,246,000 | +83.0% | 17,269 | +45.1% | 0.00% | 0.0% |
| Q3 2021 | $681,000 | +28.7% | 11,904 | -0.0% | 0.00% | 0.0% |
| Q2 2021 | $529,000 | +142.7% | 11,906 | +126.0% | 0.00% | – |
| Q4 2020 | $218,000 | -8.4% | 5,269 | +0.6% | 0.00% | – |
| Q3 2020 | $238,000 | -76.6% | 5,236 | -74.2% | 0.00% | -100.0% |
| Q2 2020 | $1,019,000 | +11.5% | 20,295 | +37.7% | 0.00% | 0.0% |
| Q4 2019 | $914,000 | – | 14,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |